How to get tested for MTHFR (and what the results mean)

Most articles on MTHFR testing jump straight to the test. That’s the wrong starting point. The first question is whether testing is warranted — and the second is which test will actually give you usable information. Get either of those wrong and you pay for a report that doesn’t change your protocol.

Here’s the practical breakdown: when to test, how to test, what the numbers mean, and what to do once you have them.

Before you test: check homocysteine first

Genetics tells you the machinery. Homocysteine tells you whether the machinery is actually failing. A fasting homocysteine blood draw is cheaper, faster, and often more clinically useful than a gene panel by itself.

Reference ranges vary, but the functional optimal is under 7 µmol/L. Above 10 suggests the methylation cycle isn’t clearing homocysteine efficiently. Above 15 is clinically elevated. A large review in JAMA on vitamins for chronic disease prevention confirmed that folate, B6, and B12 are the three nutrients that govern homocysteine metabolism and that deficiencies drive elevation (PMID 12069675).

If your homocysteine is already in the 5–7 range, you don’t have a functional methylation problem right now, regardless of your genotype. If it’s above 10, something in the methylation cycle is underperforming — and MTHFR testing becomes useful for figuring out why.

The three realistic ways to test for MTHFR

1. Single-gene MTHFR panel

The narrowest option. A blood or cheek-swab test that reports your status on two SNPs: C677T (rs1801133) and A1298C (rs1801131). These are the two variants with the strongest published association to enzyme function — the 1998 van der Put paper established that combined C677T/A1298C heterozygosity produces metabolic effects similar to C677T homozygosity alone (PMID 9545395).

• What you learn: whether you carry one, both, or neither variant, and your copy number (heterozygous or homozygous)
• What you don’t learn: any of the other methylation-cycle genes that modulate how you’ll respond to supplementation
• Typical cost: $75–$200, often covered by insurance with a practitioner order
• Good fit for: someone with elevated homocysteine, a family history of MTHFR-related issues, or recurrent pregnancy loss who wants a focused yes/no answer

2. Comprehensive nutrigenomic panel

A broader panel that analyzes MTHFR along with the genes that work around it — COMT, MTR, MTRR, MAO-A, CBS, BHMT, SHMT1, and others — plus genes that affect detoxification, neurotransmitter handling, and nutrient metabolism.

• What you learn: how your whole methylation system is wired, not just the headline gene. Critical if you’ve reacted poorly to standard methylfolate or B12 supplementation, because slow COMT carriers often overload on methyl donors
• What you don’t learn: current nutrient status — a gene panel shows capacity, not what your levels are today
• Typical cost: $150–$400 depending on depth
• Good fit for: anyone building a long-term supplementation protocol, practitioners working with complex cases, or patients who’ve had unpredictable responses to B-vitamin support

GenePro+ is built for this use case. It’s a buccal-swab panel that reports 100+ markers across 11 wellness categories and produces a practitioner-ready report — which matters, because raw genetic data without interpretation is noise.

3. Consumer DNA kit (23andMe, AncestryDNA) with third-party interpretation

The cheapest route. Consumer kits don’t report MTHFR status directly in their standard reports (most stopped doing this years ago for regulatory reasons), but they do capture the raw SNP data. You then upload that data to a third-party service like Genetic Genie, Nutrahacker, or Promethease for interpretation.

• What you learn: a lot, for little money. You’ll get MTHFR plus hundreds of other SNPs
• What you don’t learn: clinical context. Third-party interpretations vary in quality and rarely come with practitioner guidance. It’s easy to latch onto a scary-looking variant that doesn’t actually affect your biology
• Typical cost: $100 for the kit plus $5–$40 for interpretation
• Good fit for: data-comfortable patients who already have a practitioner to interpret results

Q: Which test is right for me?

If you’ve never tested and just want a yes/no on MTHFR status, a single-gene panel works. If you’ve struggled with methylation-related symptoms despite standard protocols, or you want a protocol built on the full methylation cycle rather than one gene, go with a comprehensive nutrigenomics panel. The consumer kit route is cheapest but requires the most work to translate into clinical action.

What the results actually mean

The results report will list your genotype at each SNP. Here’s what you’re looking at:

C677T (rs1801133)

• CC (wild-type): no variant. Normal enzyme activity.
• CT (heterozygous): one copy. Roughly 30–40% reduction in MTHFR activity.
• TT (homozygous): two copies. Roughly 60–70% reduction in activity and the strongest associations with elevated homocysteine.

A meta-analysis of 21 studies found the C677T polymorphism was associated with premature coronary artery disease, and the association was strongest in subjects with elevated homocysteine (PMID 25839940). A separate meta-analysis of 15 Parkinson’s disease studies confirmed the T allele is an independent risk factor for elevated homocysteine in both patients and controls (PMID 25564416).

A1298C (rs1801131)

• AA: no variant.
• AC: one copy. Mild effect on enzyme function.
• CC: two copies. Moderate effect.

A1298C alone has a milder effect than C677T. It matters most when paired with a C677T variant — the compound heterozygous state (one C677T + one A1298C) produces metabolic effects similar to C677T homozygosity.

What “compound heterozygous” means

If you inherit one copy of C677T from one parent and one copy of A1298C from the other, you’re compound heterozygous. Functionally, you behave more like a C677T homozygote than a simple heterozygote. This is one of the reasons a test that reports both SNPs is more useful than one that reports only C677T.

What to do with the results

A variant, by itself, changes nothing. What changes based on the result is your supplementation strategy and how you interpret functional markers.

If you test negative on both SNPs and your homocysteine is normal: You don’t need MTHFR-specific intervention. Standard dietary folate (leafy greens, legumes) plus a quality multivitamin is sufficient. Read more on folate forms if you want to understand the options.

If you test positive on one or both SNPs and your homocysteine is normal: You’re a carrier with functional methylation. Consider prophylactic bioactive folate, especially if planning pregnancy or nearing cardiovascular-risk age. Methylation Complete™ delivers the three bioactive B’s in daily maintenance doses.

If you test positive and your homocysteine is elevated: You have both the genetic and the functional signal. This is where targeted, higher-dose bioactive folate matters. Methyl Folate Plus™ is built for this — clinical-dose L-5-MTHF plus folinic acid plus the B2/B3 cofactors MTHFR requires to function. Recheck homocysteine at 8–12 weeks.

If you test positive and you’re planning pregnancy: Bioactive folate before conception is the evidence-supported move, particularly for carriers. This is covered in its own article because the considerations are specific.

The short version

• Check homocysteine first. If it’s below 7, genetic testing is informational rather than clinically urgent.
• Single-gene MTHFR panels cover C677T and A1298C for $75–$200. Useful if you want a focused answer.
• Comprehensive nutrigenomics panels (GenePro+ is one) cost more but cover the whole methylation cycle — worth it if you’re building a long-term protocol or have had unpredictable supplement reactions.
• Genotype alone doesn’t determine intervention. Genotype plus homocysteine plus symptoms does.
• Once you have results, the strategy is straightforward: bioactive folate matched to the severity of the variant and the functional markers.

If you want the full picture rather than the narrow test, GenePro+ is the practitioner-grade panel built for clinical protocol-building. If you already know you’re MTHFR-positive and want the daily formula, Methylation Complete™ covers the whole trio — bioactive B12, B6, and 5-MTHF.

---

This article is educational and does not constitute medical advice. Genetic testing results should be interpreted in clinical context, ideally with a practitioner familiar with methylation biology.

References

1. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA. 2002. PMID 12069675
2. van der Put NM et al. A second common mutation in the methylenetetrahydrofolate reductase gene. Am J Hum Genet. 1998. PMID 9545395
3. Hou X et al. Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: A meta-analysis. Gene. 2015. PMID 25839940
4. Zhu Y et al. Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson’s disease: a meta-analysis. Neurol Sci. 2015. PMID 25564416